Patents by Inventor Elena A. ROZHKOVA

Elena A. ROZHKOVA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11754648
    Abstract: A significant enhancement of detection capabilities of the room temperature MPQ is seen using optical lithography-defined, ferromagnetic iron-nickel alloy microdisks. Irreversible transitions between strongly non-collinear (vortex) and a collinear single domain states, driven by an ac magnetic field, translate into a nonlinear magnetic response that enables ultrasensitive detection of material at relatively small magnetic fields.
    Type: Grant
    Filed: January 25, 2021
    Date of Patent: September 12, 2023
    Assignee: UChicago Argonne, LLC
    Inventors: Valentine Novosad, Elena A. Rozhkova, Maxim Nikitin, Petr Nikitin
  • Publication number: 20210315929
    Abstract: Products and methods for redirecting the pathological biochemical process of accumulation of reduced pyridine nucleotides under deleterious hypoxia conditions toward the reduction of the precursor salt and the biosynthesis of biologically compatible, antioxidant noble metal nanoparticles and the simultaneous restoring of the tissue redox state are provided. The products and methods have application in the treatment of hypoxia and hypoxia-related diseases and disorders. Such products and methods are also useful in organ transplantation and recovery, in screening of anti-hypoxia agents, and in detecting elevated levels of the reducing equivalents of the redox state, for example, NADH, NADPH, GSH, and TrxSH2, in cells, tissues, or organs.
    Type: Application
    Filed: April 8, 2020
    Publication date: October 14, 2021
    Inventors: Elena A. Rozhkova, Elena Shevchenko
  • Publication number: 20210255257
    Abstract: A significant enhancement of detection capabilities of the room temperature MPQ is seen using optical lithography-defined, ferromagnetic iron-nickel alloy microdisks. Irreversible transitions between strongly non-collinear (vortex) and a collinear single domain states, driven by an ac magnetic field, translate into a nonlinear magnetic response that enables ultrasensitive detection of material at relatively small magnetic fields.
    Type: Application
    Filed: January 25, 2021
    Publication date: August 19, 2021
    Applicant: UCHICAGO ARGONNE, LLC
    Inventors: Valentine NOVOSAD, Elena A. ROZHKOVA, Maxim NIKITIN, Petr NIKITIN
  • Publication number: 20210060164
    Abstract: A method for performing deep tissue stimulation using radiation-enabled optogenetics including introducing a plurality of nanoscintillators into a region with light sensitive cells, and targeting the nanoscintillators with a primary radiation to cause the nanoscintillators to emit optical energy. The light sensitive cells having an optically active wavelength range, and the emitted optical energy having a wavelength in the optically active wavelength range. In particular, introducing X-ray excited optical luminescent nanomaterials to a tissue region and controlling electrical activity in cells containing opsins.
    Type: Application
    Filed: August 27, 2019
    Publication date: March 4, 2021
    Inventors: Elena A. Rozhkova, Zhaowei Chen, Vassiliy Tsytsarev
  • Patent number: 10901051
    Abstract: A significant enhancement of detection capabilities of the room temperature MPQ is seen using optical lithography-defined, ferromagnetic iron-nickel alloy microdisks. Irreversible transitions between strongly non-collinear (vortex) and a collinear single domain states, driven by an ac magnetic field, translate into a nonlinear magnetic response that enables ultrasensitive detection of material at relatively small magnetic fields.
    Type: Grant
    Filed: August 15, 2017
    Date of Patent: January 26, 2021
    Assignee: UChicago Argonne, LLC
    Inventors: Valentine Novosad, Elena A. Rozhkova, Maxim Nikitin, Petr Nikitin
  • Patent number: 10525146
    Abstract: A nanostructure comprises a MOX NP and a bidentate ligand on a surface of the MOX NP. A cancer recognition molecule is covalent coupled to the surface of the MOX NP via the bidentate ligand. A biocatalyst is also coupled to the surface of the MOX nanoparticle via the bidentate ligand. The cancer recognition molecule includes a structure configured to selectively recognize a corresponding antigen on a surface of a cancer cell and bind to the antigen. The biocatalyst is structured to selectively catalyze the oxidation of a light emitting compound to produce photons. The photons transform the MOX NPs into an excited state such that the MOX NPs generate reactive oxygen species (ROS) in the vicinity of the cancer cells in the excited state. The reactive oxygen species lyse or cause apoptosis in the cancer cells in situ. The biocatalyst includes luciferase and the light emitting compound includes luciferin.
    Type: Grant
    Filed: April 16, 2019
    Date of Patent: January 7, 2020
    Assignee: UChicago Argonne, LLC
    Inventors: Tijana Rajh, Elena A. Rozhkova, Harry C. Fry, Nada Dimitrijevic, Tamara Koritarov
  • Publication number: 20190240347
    Abstract: A nanostructure comprises a MOX NP and a bidentate ligand on a surface of the MOX NP. A cancer recognition molecule is covalent coupled to the surface of the MOX NP via the bidentate ligand. A biocatalyst is also coupled to the surface of the MOX nanoparticle via the bidentate ligand. The cancer recognition molecule includes a structure configured to selectively recognize a corresponding antigen on a surface of a cancer cell and bind to the antigen. The biocatalyst is structured to selectively catalyze the oxidation of a light emitting compound to produce photons. The photons transform the MOX NPs into an excited state such that the MOX NPs generate reactive oxygen species (ROS) in the vicinity of the cancer cells in the excited state. The reactive oxygen species lyse or cause apoptosis in the cancer cells in situ. The biocatalyst includes luciferase and the light emitting compound includes luciferin.
    Type: Application
    Filed: April 16, 2019
    Publication date: August 8, 2019
    Inventors: Tijana RAJH, Elena A. ROZHKOVA, Harry C. FRY, Nada DIMITRIJEVIC, Tamara KORITAROV, Bartosz Gryzbowski
  • Patent number: 10220378
    Abstract: Aspects of the disclosure relate to an efficient entirely man-made nanobio hybrid fabricated through cell-free expression of transmembrane proton pump followed by assembly of the synthetic protein architecture with semiconductor nanoparticles for photocatalytic H2 evolution. The system produces H2 at a turnover rate of 240 ?mol of H2 (?mol protein)?1 h?1 under green and 17.74 mmol of H2 (?mol protein)?1 h?1 under white light at ambient conditions, in water at neutral pH with methanol as a sacrificial electron donor. Robsutness and flexibility of this approach allows for systemic manipulation at nanoparticle-bio interface toward directed evolution of energy materials and devices.
    Type: Grant
    Filed: June 1, 2017
    Date of Patent: March 5, 2019
    Assignee: UChicago Argonne, LLC
    Inventors: Elena A. Rozhkova, Peng Wang, Richard D. Schaller, Nada M. Dimitrijevic, Tijana Rajh, Shankar G. Balasubramanian
  • Publication number: 20190056463
    Abstract: A significant enhancement of detection capabilities of the room temperature MPQ is seen using optical lithography-defined, ferromagnetic iron-nickel alloy microdisks. Irreversible transitions between strongly non-collinear (vortex) and a collinear single domain states, driven by an ac magnetic field, translate into a nonlinear magnetic response that enables ultrasensitive detection of material at relatively small magnetic fields.
    Type: Application
    Filed: August 15, 2017
    Publication date: February 21, 2019
    Inventors: Valentine NOVOSAD, Elena A. ROZHKOVA, Maxim NIKITIN, Petr NIKITIN
  • Publication number: 20180345263
    Abstract: Aspects of the disclosure relate to an efficient entirely man-made nanobio hybrid fabricated through cell-free expression of transmembrane proton pump followed by assembly of the synthetic protein architecture with semiconductor nanoparticles for photocatalytic H2 evolution. The system produces H2 at a turnover rate of 240 ?mol of H2 (?mol protein)?1 h?1 under green and 17.74 mmol of H2 (?mol protein)?1 h?1 under white light at ambient conditions, in water at neutral pH with methanol as a sacrificial electron donor. Robsutness and flexibility of this approach allows for systemic manipulation at nanoparticle-bio interface toward directed evolution of energy materials and devices.
    Type: Application
    Filed: June 1, 2017
    Publication date: December 6, 2018
    Inventors: Elena A. ROZHKOVA, Peng WANG, Richard D. SCHALLER, Nada M. DIMITRIJEVIC, Tijana RAJH, Shankar G. BALASUBRAMANIAN
  • Publication number: 20180036426
    Abstract: A nanostructure comprises a MOX NP and a bidentate ligand on a surface of the MOX NP. A cancer recognition molecule is covalent coupled to the surface of the MOX NP via the bidentate ligand. A biocatalyst is also coupled to the surface of the MOX nanoparticle via the bidentate ligand. The cancer recognition molecule includes a structure configured to selectively recognize a corresponding antigen on a surface of a cancer cell and bind to the antigen. The biocatalyst is structured to selectively catalyze the oxidation of a light emitting compound to produce photons. The photons transform the MOX NPs into an excited state such that the MOX NPs generate reactive oxygen species (ROS) in the vicinity of the cancer cells in the excited state. The reactive oxygen species lyse or cause apoptosis in the cancer cells in situ. The biocatalyst includes luciferase and the light emitting compound includes luciferin.
    Type: Application
    Filed: March 31, 2016
    Publication date: February 8, 2018
    Inventors: Tijana RAJH, Bartosz GRYZBOWSKI, Elena A. ROZHKOVA, Harry C. FRY, Nada DIMITRIJEVIC, Tamara KORITAROV